← Leaderboards
Dennis W Stacey
Cleveland Clinic Foundation
$3,110,331
Attributed
$3,110,331
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $344.3K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$3,110,331 · 2
By mechanism
R01$3,110,331 · 2
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Ganes C. Sen$23,043,702
- Yan Xu$4,438,394
- Alan Wolfman$1,163,650
- Ram N. Ganapathi$3,109,959
- Paul E Dicorleto$10,288,247
Others in their field
Top investigators on “Messenger Rna”
- Jeffrey P Krischer · University Of South Florida$206,732,287
- David Heimbrook · Leidos Biomedical Research, Inc.$96,474,613
- Henry F Chambers · Duke University$47,759,573
- Vance G Fowler · Duke University$46,487,462
- Barton F Haynes · Duke University$43,472,529
- Bradley F Boeve · Mayo Clinic Rochester$42,990,413
Research focus
Messenger RnaCell CycleGuanine Nucleotide Binding ProteinCell Growth RegulationBiological Signal TransductionCyclinsCell ProliferationEnzyme ActivityEnzyme Induction /RepressionIn Situ HybridizationBreast NeoplasmsBladder NeoplasmGene MutationGenetic Promoter Element3t3 CellsProtein Protein InteractionOncoproteinsDna TopoisomerasesTissue /Cell CultureEnzyme Linked Immunosorbent AssayGel ElectrophoresisGene ExpressionImmunoprecipitationMicroinjections
Grant awards (11)
Function of RAS Activity Late in the Cell Cycle$336,161
R01 · FY2006 · GM · contact PI
Function of RAS Activity Late in the Cell Cycle$344,250
R01 · FY2005 · GM
Function of RAS Activity Late in the Cell Cycle$344,250
R01 · FY2004 · GM
Control of topoisomerose II through the cell cycle$222,233
R01 · FY2004 · CA
Function of RAS Activity Late in the Cell Cycle$345,550
R01 · FY2003 · GM
Control of topoisomerose II through the cell cycle$222,233
R01 · FY2003 · CA
FUNCTION OF RAS ACTIVITY LATE IN THE CELL CYCLE$295,380
R01 · FY2002 · GM
Control of topoisomerose II through the cell cycle$214,970
R01 · FY2002 · CA
FUNCTION OF RAS ACTIVITY LATE IN THE CELL CYCLE$288,642
R01 · FY2001 · GM
Control of topoisomerose II through the cell cycle$214,970
R01 · FY2001 · CA
FUNCTION OF RAS ACTIVITY LATE IN THE CELL CYCLE$281,692
R01 · FY2000 · GM